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A B S T R A C T
Peroxisomes are ubiquitous cellular organelles required for specific pathways of fatty acid oxidation and lipid
synthesis, and until recently their functions in adipocytes have not been well appreciated. Importantly, per-
oxisomes host many oxygen-consumption reactions and play a major role in generation and detoxification of
reactive oxygen species (ROS) and reactive nitrogen species (RNS), influencing whole cell redox status. Here, we
review recent progress in peroxisomal functions in lipid metabolism as related to ROS/RNS metabolism and
discuss the roles of peroxisomal redox homeostasis in adipogenesis and adipocyte metabolism. We provide a
framework for understanding redox regulation of peroxisomal functions in adipocytes together with testable
hypotheses for developing therapies for obesity and the related metabolic diseases.
1. Introduction
The ability of adipose tissues to dispose of circulating fatty acids
(FA) by storage as triacylglycerols (TAG) or by oxidation has important
metabolic and clinical implications [1]. Increased and dysregulated FA
disposal contributes to the accumulation of potentially harmful FA
metabolites in peripheral organs, which can cause insulin resistance
and cardiometabolic diseases [2]. In addition, adverse remodeling and
expansion of white adipose tissue (WAT) is associated with alterations
in metabolic function and adipokine secretion, and accelerated devel-
opment of insulin resistance [3]. The expansion of adipose depots can
be driven either by the increase in adipocyte size (hypertrophy) or by
the formation of new adipocytes differentiated from their precursors
(hyperplasia). Based on different adipogenic sites, WAT is usually di-
vided into subcutaneous and visceral depots, which have intrinsically
different metabolic functions in maintaining health. The propensity to
generate new adipocytes varies between the different adipose depots,
and these processes are differentially regulated and have different
metabolic consequences [4].
Reactive oxygen species (ROS) and reactive nitrogen species (RNS)
are signaling messengers that mediate various biological responses. The
primary ROS/RNS species generated in cells are superoxide radical
(O2%-), hydrogen peroxide (H2O2), hydroxyl radical (%OH), and nitric
oxide radical (%NO) and its derivative peroxynitrite (ONOO−) [5].
Obesity is often associated with an imbalance in oxidation-reduction
(redox) in WAT, which contributes to adipocyte dysfunction and can
inhibit the insulin signaling cascade [6,7]. Mitochondria and peroxi-
somes are involved in major cellular catabolic pathways that are the
major sources of ROS generation. Mitochondrial ROS signaling in
supporting adipocyte thermogenic identity and function has been de-
monstrated in numerous animal and cellular models [8]. In contrast,
much less is known about peroxisomes, where FA oxidation is coupled
with the generation of H2O2 and minimal ATP production.
Peroxisomes are dynamic cellular organelles with diverse metabolic
functions. Increase of peroxisomal gene expression and peroxisomal
proliferation were observed during both brown and white adipogenesis
[9]. In adipocytes, peroxisomes generate a variety of signaling mole-
cules that are involved in regulating adipogenesis and adipocyte FA
metabolism. Peroxisomes are named based on their function in pro-
ducing and detoxifying H2O2 that serves as a cellular redox buffering
system [10]. Despite the widespread perception that ROS are toxic by-
products of aerobic metabolism, there is increasing evidence that ROS
https://doi.org/10.1016/j.redox.2019.101167
Received 16 December 2018; Received in revised form 1 March 2019; Accepted 10 March 2019
Abbreviations: Akt, protein kinase B; ACOX, acyl-CoA oxidase; BCFA, branched chain fatty acid; BAT, brown adipose tissue; C/EBPα, CCAAT-enhancer binding
protein α; DHAP, dihydroxy acetone phosphate; EET, epoxyeicosatrienoic acid; FA, fatty acid; FAS, fatty acid synthase; H2O2, hydrogen peroxide; HACL1, 2-
hydroxyacyl-CoA lyase 1; HAOX, L-hydroxy acid oxidase; HFD, high fat diet; iNOS, inducible nitric oxide synthase; JNK, c-Jun N-terminal kinase; LDs, lipid droplets;
2-OHFA, 2-hydroxy fatty acid; PPARγ, peroxisome proliferator-activated receptor γ; PRDX5, peroxiredoxin 5; PUFA, polyunsaturated fatty acid; RNS, reactive
nitrogen species; ROS, reactive oxygen species; RXR, retinoid X receptor; sEH, soluble epoxide hydrolase; SOD, superoxide dismutase; TAG, triacylglycerol; VLCFA,
very long chain fatty acid; WAT, white adipose tissue
∗ Corresponding author. Soochow University Medical College, 199 Ren'ai Rd, Suzhou, 215123, China.
E-mail address: xsu@suda.edu.cn (X. Su).
Redox Biology 24 (2019) 101167
Available online 14 March 2019
2213-2317/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
species can act as signaling molecules involved in cellular metabolic
functions, including cell proliferation, differentiation, migration, and
apoptosis [11]. Moreover, accumulating evidence supports that perox-
isomal functions as related to ROS metabolism undergo differential
dynamic regulation in different adipose depots. In this paper, we review
the importance of peroxisomal redox signaling in adipogenesis and
adipocyte metabolism.
2. Overview of the metabolic pathways in peroxisomes
Lipid storage and utilization rely on the interplay among the en-
doplasmic reticulum (ER), mitochondria, peroxisomes and lipid dro-
plets (LD) [12]. Peroxisomes uniquely integrate cellular lipid storage
and removal where FAs can be conjugated with dihydroxyacetone
phosphate (DHAP) to synthesize glycerolipids or be shuttled into oxi-
dative pathways [13]. Peroxisomes are involved in a broad range of
metabolic pathways in humans that include: 1) FA β-oxidation; 2) FA α-
oxidation; 3) ether lipid synthesis; 4) bile acid synthesis, 5) amino acid
catabolism and 6) glyoxylate detoxification [13]. The importance of
peroxisome lipid metabolism in human health is highlighted by the
observations made in patients with Zellweger syndrome, who have a
reduction or absence of functional peroxisomes that cause an accumu-
lation of plasma very-long-chain FA (VLCFA) and branched chain FA
(BCFA) and impaired function in multiple organs [14], including brain
and lung functions [13].
3. ROS-generating pathways in peroxisomes
Peroxisomal FA oxidation shows substrate preference for VLCFA, 2-
methyl-BCFA (e.g. pristanic acid), 2-hydroxy FA (2-OHFA), long chain
dicarboxylic acid, polyunsaturated FA (PUFA) and precursors of bile
acids. In contrast with mitochondrial FA β-oxidation initiated by acyl-
CoA dehydrogenases and coupled to generation of FADH2, peroxisomal
FA β-oxidation is initiated by fatty acyl-CoA oxidases (ACOXs) with
generation of H2O2. The resulting acetyl-CoA and acyl-CoAs with
shorter chain length are converted to their carnitine conjugates, ex-
ported out of peroxisomes and taken up by mitochondria for complete
oxidation (Fig. 1).
Peroxisomal FA α-oxidation is another pathway influencing cellular
ROS generation. Phytanic acid with a methyl group at the C3 position
prevents its degradation by β−oxidation, but can be converted into
pristanic acid by α oxidation [13]. This reaction is initiated by phyta-
noyl CoA hydroxylase (PHYH) using O2 as electron acceptor. The re-
sulting 2-hydroxyphytanoyl-CoA is processed sequentially by 2-hydro-
xyacyl-CoA lyase 1 (HACL1) and by an unknown peroxisomal aldehyde
dehydrogenase. Treatment of SH-SY5Y cells and astrocytes with phy-
tanic acid results in higher ROS generation, suggesting that the overall
metabolism of pristanic acid contributed to higher cellular oxidative
stress [15]. Another group of FA substrates that undergo α-oxidation is
straight chain 2-hydroxy FA (2-OHFA), (R)-enantiomers of which can
be oxidized by HACL1 [16] and (S)-enantiomers by α-hydroxy acid
oxidases (HAOX1 and HAOX2) leading to H2O2 release [17] (Fig. 1).
Moreover, formate generated by FA α-oxidation can influence cellular
ROS generation by stimulating mitochondrial superoxide/hydrogen
peroxide release [18].
Additional peroxisomal ROS-producing oxidative enzymes are D-
amino acid oxidase, D-aspartate oxidase, L-pipecolic acid oxidase,
polyamine oxidase, xanthine oxidase (XDH) and many heme-containing
enzymes [19]. H2O2 and the superoxide anion O2%- are usually gener-
ated as byproducts of their catalytic cycle. O2%- reacts rapidly with H2O2
and nitrates to generate hydroperoxide species and the highly oxidative
ONOO−. O2%- can also be dismutated to form H2O2, which is decom-
posed through the Fenton reaction to %OH. The peroxisomal ROS spe-
cies react rapidly with lipids to form lipid radicals and lipid peroxida-
tion derivatives and with proteins to instigate damage [20]. Moreover,
peroxisomes contain inducible nitric oxide synthase (iNOS), which
catalyzes the oxidation of L-arginine to generate %NO; targeted disrup-
tion of the iNOS gene decreases adipose tissue inflammation [21]
(Fig. 2).
4. Peroxisomal ROS/RNS buffering systems
Multiple antioxidant systems have evolved within peroxisomes to
detoxify ROS/RNS and maintain redox homeostasis. The identified
peroxisomal antioxidant enzymes include catalase, superoxide dis-
mutases (SODs), peroxidases, peroxiredoxin I and V, and soluble ep-
oxide hydrolase (sEH). The copper-zinc SOD (SOD1) is the cytoplasmic
isoform without an endogenous peroxisomal targeting sequence, but
can be targeted to peroxisomes by using its physiological interaction
partner, copper chaperone of SOD1, as a shuttle [22]. SOD catalyzes the
dismutation of O2%- radical into O2 and H2O2, which are then removed
by catalase and glutathione peroxidase within peroxisomes [23]. Per-
oxisomal peroxidases remove superoxide anion-induced lipid radicals
and organic hydroperoxide species, and peroxiredoxin I and peroxir-
edoxin V control peroxide levels [24]. The epoxy FA neutralizing en-
zyme sEH has been localized in both the cytosol and peroxisomes, and
the monomeric form with disrupting dimerization is preferentially
targeted to peroxisomes [25]. Finally, peroxisomes also contain several
proteases whose functions are linked to ROS-production. Peroxisomal
lon peptidase 2 (LonP2), an ATP-dependent serine protease, is
Fig. 1. Metabolic pathways in peroxisomes and redox regulation. Enzymes in red are known to generate ROS or act as antioxidants. Metabolites in blue act as
non-enzymatic antioxidants. Refer to the text for details. ACOX, acyl-CoA oxidase; Alkyl-G3P, 1-O-alkyl glycerol-3-phosphate; DBP, D-bifunctional protein; DHAP,
dihydroxy acetone phosphate; HAOX, L-hydroxy acid oxidase; HACL1, 2-hydroxyacyl-CoA lyase 1; LBP, L-bifunctional protein; 2-OHFA, 2-hydroxy fatty acid; PHYH,
phytanoyl-CoA 2-hydroxylase; PUFA, poly unsaturated fatty acid; VLCFA, very long chain fatty acid.
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implicated in the degradation of damaged proteins by oxidation due to
increased ROS levels, leading to regulation of FA β-oxidation in per-
oxisomal matrix [26] (Fig. 2).
In addition to the catabolism of various FAs, peroxisomes harbor
metabolic enzymes initiating the synthesis of plasmalogens with vinyl
ether linkage, which can function as non-enzymatic antioxidants [27].
Vinyl ether lipids prevent the propagation of lipid peroxidation [28]
and their deficiency makes cells more vulnerable to oxidative stress
[29,30]. Other small molecule antioxidants in peroxisomes include
glutathione and ascorbic acid (vitamin C). Removal of H2O2 is coupled
to the oxidation of GSH to GSSG and the subsequent regeneration of
GSH requires glutathione reductase as well as NADPH (Fig. 2). The
oxidized GSSG may be exported out of peroxisomes for GSH re-
generation in cytosol and be re-uptaken to eliminate ROS.
NAD(P)H plays an important role in both peroxisomal ROS gen-
eration and elimination. Peroxisomes contain two different systems to
regenerate NADPH: the pentose phosphate pathway (PPP) and the
isocitrate dehydrogenase (IDH) pathway. Since NADPH is more abun-
dant than NADH, peroxisomal redox status is often evaluated by as-
sessing the NADPH/NADP+ ratio. NADPH can slowly diffuse out of the
peroxisome in vitro, suggesting that peroxisomal NADPH/NADP+ is
able to influence redox potential in cytosol [31]. In contrast, re-
generation of NADH, which is required for continuous β-oxidation in
peroxisomes, is accomplished by a pyruvate-lactate redox shuttle lo-
calized on the peroxisomal membrane [32].
5. Peroxisomal regulation of adipogenesis
Accumulating evidence supports the importance of peroxisomes in
the regulation of white and brown adipocyte differentiation (adipo-
genesis). Adipogenesis relies on a delicate transcriptional program in-
cluding CCAAT-enhancer binding protein α (C/EBPα) and peroxisome
proliferator-activated receptor (PPARγ) that are also involved in the
regulation of peroxisome proliferation in adipocytes [33]. Peroxisomes
are essential for the metabolism of PUFA, providing natural ligands for
PPARγ [34]. Additionally, 1-O-octadecenyl-2-palmitoyl-3-glyceropho-
sphocholine (18:1e/16:0-GPC) has been identified as a potential en-
dogenous ligand for PPARγ [35] and monoalkylglycerol ether lipids as a
new class of adipogenic promoters [36]. The peroxisomal ether lipid
synthesis may thus represent a positive feedback loop to sustain the
adipogenic program. In addition to its signaling functions in promoting
adipogenesis, peroxisomes are also significantly involved in TAG
synthesis (lipogenesis). In cultured adipocytes, peroxisomes initiated
the synthesis of almost half of the TAG [37] and were closely associated
with LD [12]. Approximately 10–20% of the neutral lipids in LD were
the ether lipid, monoalk(en)yl diacylglycerol, whose synthesis was
exclusively initiated in peroxisomes [38]. Silencing of Pex16 in 3T3-L1
cells impaired adipocyte differentiation and cellular TAG stores, which
are rescued by addition of PPARγ agonist rosiglitazone and peroxisome-
related lipid species, highlighting the relevance of peroxisomes for
adipogenesis [39]. Pex7 knockout mice, which are characterized by the
absence of plasmalogens, have markedly reduced WAT and abnormally
small LD within the cytoplasm of individual brown adipocytes [40]. In
contrast, aP2-Pex5 conditional knockout mice showed dysfunctional
WAT with increased fat mass and reduced lipolysis, which may be due
to nonselective inhibition of peroxisomal functions in nervous system
by the aP2 promotor, leading to reduced levels of catecholamine [41].
However, based on normal white adipose and muscle function in Nestin-
Pex5 and Wnt-Pex5 knockout mice respectively, it is unlikely that per-
oxisome absence from the central and peripheral nervous system caused
the observed adipose phenotype. Understanding PEX5 regulation of
adipose expansion in vivo requires additional models of Pex5 deficiency
specific in adipose. Collectively, these data indicate that biogenesis of
peroxisomes provides signaling lipids to promote adipogenesis and
regulate lipogenesis.
6. Redox regulation of adipogenesis
Chronic stimulation of ROS production in adipose during unhealthy
obesity is associated with inhibited insulin signaling and thus impaired
adipogenesis [42]. Peroxisomes may influence adipogenesis by reg-
ulating ROS homeostasis and multiple mechanisms have been proposed
for ROS regulation of adipogenesis. Inhibition of complex I and ATP
synthase increases cellular H2O2 and may act as anti-growth signal on
3T3-L1 preadipocytes to impair their potential to differentiate [43]. The
preadipocytes acquire resistance against oxidative stress via FoxO-
regulated expression of ROS-scavenging enzymes during differentiation
[44] and in vitro study reveals that oxidative stress decreased GLUT4
expression and lipogenesis by diminished binding of C/EBP-dimer to
GLUT4 promoter [45]. This regulation is supported by recent study that
4-hydroxynonenal (4-HNE)-induced oxidative stress impairs the adi-
pogenic capacity of preadipocytes obtained from human subjects [46].
Moreover, cellular redox homeostasis may function through multiple
crucial adipogenic transcriptional factors including C/EBPs, PPARγ,
retinoid X receptor (RXR) as well as PPARγ coactivator 1α (PGC1α),
whose activities are sensitive to their phosphorylation by a myriad of
redox sensitive kinase pathways including c-Jun N-terminal kinase
(JNK), p38-mitogen-activated protein kinase (MAPK), extracellular
signal-regulated kinase (ERK) and protein kinase B (Akt) pathways
[47]. Specifically, an increase in ROS by treatment with octanoate in
adipocytes was linked to a decrease in TAG synthesis, and reduction of
lipogenic gene expression by inactivation of PPARγ [48].
Fig. 2. Peroxisomal ROS scavenge system. Red
characters denote ROS/RNS and macromolecular
damaged by ROS. Blue characters denote none-
nzymatic antioxidants. Refer to the text for details.
GPX, glutathione peroxidase; GR, glutathione re-
ductase; GSH, reduced glutathione; GSSG, oxidized
glutathione; H2O2, hydrogen peroxide; iNOS, in-
ducible nitric oxide synthase; L%, lipid radical; LOO%,
lipid peroxyl radical; LOOH, lipid peroxide; LOH,
lipid alcohol; LONP2, Lon protease 2; %NO, nitric
oxide radical; O2%-, superoxide radical; OH%, hydroxyl
radical; ONOO−, peroxynitrite; PRDX, peroxir-
edoxin; PUFA, polyunsaturated fatty acid; SOD, su-
peroxide mutase.
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On the other hand, accumulating evidence supports that ROS gen-
eration seems important for adipocyte differentiation. Adipogenic dif-
ferentiation in the 3T3-L1 preadipocytes were stimulated by addition of
H2O2 [49]. Moreover, increased endogenous ROS production is ob-
served even with enhanced expression of ROS-scavenging enzymes [44]
in differentiating 3T3-L1 cells and in primary human mesenchymal
stem cells undergoing differentiation into adipocytes [50]. This stimu-
lated ROS generation facilitates adipocyte differentiation by enhancing
C/EBPβ DNA binding activity and accelerating mitotic clonal expansion
during early stage of differentiation [51]. Conversely, decrease of in-
tracellular ROS or addition of antioxidants inhibits adipocyte differ-
entiation [52,53]. Mutual interaction between ROS and insulin sig-
naling has significant impact on adipogenesis. ROS generation through
activation of NADPH oxidase homolog -NOX4 induces insulin signaling
and adipogenesis by inhibiting protein phosphatase PIP1B [54]. Alter-
natively, oxidative stress inhibits expression of the adipogenic sup-
pressor Sirt1, inducing adipogenesis along with adipocyte hypertrophy
in mesenchymal stem cells and mouse pre-adipocytes [55]. Moreover,
Sirt1 activity is sensitive to [NAD+]/[NADH] ratio which impact the
acetylation status and metabolic functions of the adipogenic tran-
scriptional factors [56,57].
The involvement of %NO in regulating adipogenesis and adipocyte
biology has also been studied. %NO is essential for maintaining the
balance between osteoblast and adipocyte lineage differentiation in
periodontal ligament stem cells via the JNK/MARK signaling pathway.
Increasing the physiological level of %NO with sodium nitroprusside
significantly promoted the osteogenic differentiation capacity, but re-
duced its adipogenic differentiation capacity [58]. In contrast, a posi-
tive role of %NO in modulating adipogenesis is evidenced in cultured
preadipocytes. %NO level in preadipocytes derived from rat WAT is in-
creased during the early phase of differentiation and its deprivation
partially abrogated the differentiation process [59]. S-nitrosylation of
fatty acid synthase induced by %NO increases its activity through di-
merization and may contribute to %NO regulation of adipogenesis [60].
Collectively, different cellular ROS and RNS may play distinct roles in
different stages of adipogenesis [6], whose effects are determined by
the levels and duration of specific oxidative signaling.
7. Depot-dependent redox regulation in adipose
Although brown adipose tissue (BAT) and WAT have comparable
levels of ROS in mice under chow diet, BAT is more sensitive to HFD-
induced ROS production [61]. Meanwhile, high fat feeding also in-
creases expression of peroxisomal genes in BAT [9], suggesting poten-
tial involvement of peroxisomes in BAT ROS metabolism. Regulation of
ROS metabolism in WAT also shows depot dependency. Mouse visceral
WAT exhibits higher ROS as compared with the subcutaneous depot
and aging induces ROS in visceral, but not in subcutaneous depot [62].
In humans, obesity is associated with lower GSH levels in both WAT
depots, but additional pro-oxidative changes exist only in visceral WAT,
which may be signs of visceral WAT metabolic dysfunction [63]. Cho-
lesterol epoxide increases the expression of α-oxidation related genes in
visceral adipocytes of obese subjects, but not in the subcutaneous adi-
pocytes [64]. Collectively, these observations point out the complex
regulation of oxidative stress in WAT depots and ROS in visceral WAT
seems more sensitive to regulation by aging and obesity. However,
contribution of peroxisomes in the depot-specific regulation of ROS
metabolism remains to be determined.
8. Peroxisomal redox signaling in adipogenesis
Peroxisome biogenesis and its capacity for lipid metabolism dra-
matically increase during adipogenesis [65,66], suggesting that per-
oxisome proliferation can act as a positive feedback circuit to support
adipocyte lipid metabolism and differentiation. Accumulating evidence
supports that peroxisomal ROS generation promotes adipogenesis and
adipocyte hypertrophy. Treatment with a SOD mimetics reduces visc-
eral adiposity in mice through a reduction in adipocyte hypertrophy
and adipogenesis, suggesting a causal role for ROS in the response to
increased energy intake and diet-induced obesity [67]. Epoxyeicosa-
trienoic acid (EET), a type of PUFA that could act as an endogenous
antioxidant, reduces adipogenesis in human mesenchymal stem cells
and mouse 3T3-L1 preadipocytes, and injection of EET leads to reduced
weight gain in obese mice [68]. Deletion of sEH that removes EET re-
sults in a significant decrease in adipocyte size and a decrease in visc-
eral fat by reprograming of WAT to express mitochondrial and ther-
mogenic genes, a characteristic phenotype of beige fat [69].
Conversely, silencing peroxiredoxin 5 (PRDX5) promotes preadipocytes
to differentiate into adipocytes and Prdx5 knockout mice exhibit sig-
nificant increase in body weight and enormous fat pads, suggesting ROS
regulation of adipogenic gene expression and adipogenesis [70]. Simi-
larly, catalase knockout mice exhibit an obese phenotype, manifested as
an increase in body weight that becomes more pronounced with age
and develop a pre-diabetic phenotype [71].
In contrast, a recent study using mouse models with peroxisomal
ROS metabolism manipulated specifically in adipocytes suggests that
oxidative stress inhibits healthy adipose expansion [72]. SOD1 and
catalase over-expression in adipocytes exhibit adipose expansion with
decreased ectopic lipid accumulation and improved insulin sensitivity,
potentially by attenuation of SREBF1-mediated lipogenic transcrip-
tional activities [72]. These data support the idea that peroxisomal
functions in ROS metabolism and adipogenic transcriptional activation
synergistically regulate lipid synthesis and expansion of adipose tissue.
More importantly, it seems that ROS regulation of adipogenesis might
contribute to WAT remodeling and determine its impact on peripheral
tissues. The overall effect of peroxisomal ROS in adipogenesis and
adipocyte functions is determined by temporal regulation of specific
metabolic pathways of ROS.
9. Peroxisomal regulation of lipid mobilization
During adipogenesis, peroxisomes increase in number and form
close contact with LD. Moreover, the biogenesis of peroxisomes and LD
occur at the same ER subdomains [73], suggesting their intimate con-
nection and potential functional coupling. Potential peroxisomal reg-
ulation of lipolysis has been suggested in peroxisome deficient aP2-Pex5
knockout mice, which have reduced lipolytic rates [41]. In Sacchar-
omyces cerevisiae, peroxisomes can even extend into lipid body cores
and promote the coupling of lipolysis in lipid bodies with peroxisomal
FA oxidation, without passing through the cytosolic compartment [74].
Moreover, the coordination among LD, peroxisomes, and mitochondria
regulated by ATGL-PPARα is important for lipolysis and FA oxidation in
ob/ob mice deficient in Cidea and Cidec [75]. Lipidomics analysis of
differentiating adipocytes revealed continuous accumulation of odd
chain FAs [76], suggesting a concurrent increase in lipid turnover as
well as the peroxisomal α-oxidation activity.
Level of lipolysis in visceral adipose is higher and declines with age.
In contrast, subcutaneous adipose keeps relatively constant low level.
These depot differences are not due to different oxidative damage or
enzymatic anti-oxidant defense, but may be explained by site variations
in insulin and adrenergic signaling [77]. In humans, both basal and
adrenergic stimulated lipolysis is higher in adipocytes derived from
visceral adipose as compared to cells from subcutaneous depot [78]. In
line with depot specific regulation of lipolysis, adipocytes from visceral
fat are more insulin-resistant and more sensitive to adrenergic stimu-
lation than subcutaneous WAT.
Cellular redox state influences lipolysis in adipocytes and perox-
isomal redox signaling may contribute to its regulation of lipolysis.
Lactate inhibits lipolysis by blocking the cAMP/PKA signaling cascade
[79] and the NAD+-dependent Sirt1 deacetylase activity promotes fat
mobilization in white adipocytes by repressing PPARγ [80]. Physiolo-
gical levels of %NO produced in adipose tissue stimulates lipolysis and
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FA oxidation through both AMPK-dependent and independent me-
chanisms, whereas high %NO levels inhibit basal as well as adrenergic
stimulated lipolysis [81]. Moreover, iNOS impairs the anti-lipolytic
effect of insulin in postprandial adipocytes, possibly via increased S-
nitrosylation and inactivation of Akt/phosphodiesterase 3B axis
[82,83].
10. Peroxisomal regulation of WAT browning and metabolic
remodeling
Intake of HFD or cold exposure induces the acquisition of thermo-
genic features in subcutaneous WAT [84]. Characterization of the
transcriptional network responsible for thermogenic fat activation re-
vealed the involvement of PPARγ and PGC1α, which are key regulators
of peroxisomal proliferation [85]. HFD did not increase expression of
peroxisomal genes in WAT [9], arguing against the involvement of
peroxisomes in HFD-induced WAT browning. In contrast, cold exposure
increased the expression of genes involved in peroxisomal biogenesis in
BAT, as well as in subcutaneous WAT, which is highly susceptible to
cold-induced browning [86]. Collectively, these results suggest depot-
specific regulation of peroxisomal signaling may be involved in WAT
browning in response to cold exposure. Although higher ROS level and
more sensitive regulation are observed in visceral fat, which plays
minimal roles in thermogenic activation in response to cold exposure,
whether peroxisomal ROS signaling represents an intrinsic inhibitory
regulator of WAT browning remains elusive.
Depot specific regulation of adipokine secretion has also been ob-
served. Subcutaneous WAT is the major source of leptin, while visceral
WAT is more capable of generating adiponectin, angiotensinogen,
plasminogen activator inhibitors-1 and pro-inflammatory cytokines
[87]. Depot specific peroxisomal regulation of lipolysis, insulin sig-
naling, glucose and lipid metabolism and adipokine secretion are
mainly unknown due to unavailable depot specific manipulation of
peroxisomal signaling. However, studies using models of global or
adipose specific peroxisome deficiencies reveal important metabolic
regulation in adipose by peroxisomal signaling. Pex11a deficiency im-
pairs physical activity and energy expenditure, decreases fatty acid
oxidation, increases de novo lipogenesis and results in dyslipidaemia
and obesity [88]. aP2-Pex5 conditional knockout mice showed dys-
functional white adipose tissue with reduced lipolysis and increased
insulin resistance, suggesting that peroxisomal signaling is necessary to
maintain the adrenergic tone in mice, which in turn determines meta-
bolic homeostasis [41]. Mice with adipose-specific knockout of Pex16
have increased diet-induced obesity and impaired thermogenesis due to
inhibited plasmalogen synthesis, leading to decreased insulin sensitivity
and glucose tolerance [9].
11. Obesity-induced peroxisomal regulation in adipose tissues
In adipose biology, diabetic obesity is correlated with increased ROS
in depot-specific manner and is mechanistically linked to obesity-re-
lated metabolic diseases. Subcutaneous WAT from obese diabetic sub-
jects exhibit increased H2O2 production compared with that from lean
controls. Moreover, oxidized lipids and proteins accumulate to a greater
extent in visceral depots compared with subcutaneous depots [89].
Obesity is associated with lower GSH levels in both WAT depots [63],
but whether this redox regulation in WAT is related to peroxisomal
signaling is not clear. Levels of PGC-1α and peroxisomal markers in
BAT are lower in ob/ob mice than in lean control [75]. Moreover, as
compared to obesity-prone animal, obesity-resistant animals show en-
hanced peroxisomal β-oxidation metabolism and reduced fat accumu-
lation in visceral adipose tissues by up-regulating the expression of
peroxisomal β-oxidation marker genes, which may be driven or en-
hanced by the up-regulation of the expression of PPARα [90]. In con-
trast, HFD-induced obesity shows increased expression of peroxisomal
genes in BAT, but not in WAT [9]. These results indicate that
peroxisomal functions in adipose are not determined by obesity per se,
but may be regulated by specific pathway leading to adipose expansion
in depot-specific manner.
12. Interplay between peroxisomes and mitochondria in the
control of cellular redox signaling
Mitochondria are important in redox regulation and signaling where
spontaneous leakage of electrons to oxygen from various dehy-
drogenases and respiratory chain complexes contributes to the gen-
eration of ROS. Previous studies suggest that ROS derived from mi-
tochondria are important in the regulation of adipose expansion.
Deletion of p66(Shc), a redox enzyme that generates mitochondrial
ROS, also reduced triglyceride accumulation in adipocytes and in vivo
decreased fat mass and resistance to diet-induced obesity [91]. Prx3 KO
mice had increased fat mass with increased adipogenic transcription
factors and lipogenic gene expression, possibly due to increased oxi-
dative stress as evidenced by mitochondrial protein carbonylation [92].
Moreover, mitochondrial complex III ROS was demonstrated to be a
causal factor in promoting adipocyte differentiation [50]. In contrast,
adipose specific deletion of SOD2 increased mitochondrial superoxide
and triggered an adaptive stress response, thereby preventing diet-in-
duced obesity and insulin resistance [93], suggesting differential reg-
ulation of adipose expansion by different ROS metabolic pathways.
Peroxisomes cooperate with mitochondria in multiple metabolic
pathways that affect redox-linked physiological processes and dys-
function of one organelle may affect the redox balance and function of
the other [94]. Mitochondrial dysfunction is observed in patients with
X-linked adrenoleukodystrophy (X-ALD) and peroxisome deficiency.
Pex5 knockout mice with defective peroxisome biogenesis have altered
mitochondrial ultrastructure with increased mitochondrial fission and
changes in respiratory chain activity, and Pex13 null MEFs show mi-
tochondrial oxidative stress and altered mitochondrial dynamics [41].
Mitochondrial dysfunction is also observed in ABCD1 deficiency as well
as in Zellweger syndrome patients with Pex16 mutation [95]. In-
creasing peroxisomal FA oxidation boosts mitochondrial FA oxidation
and ROS generation, indicating an intimate relationship between per-
oxisomes and mitochondria in regulating substrate oxidation and cel-
lular redox status. On the other hand, inhibition of FA transport into
mitochondria by Cpt1 knockout increases adaptive expression of per-
oxisomal FA oxidation genes, suggesting the presence of a mitochon-
drial retrograde signaling to regulate peroxisomal FA oxidation [96]. A
recent publication supports a surprising interaction between peroxi-
somes and mitochondria. Peroxisomes regulate mitochondrial dy-
namics and thermogenesis, by directing plasmalogens to mitochondria
to mediate mitochondrial fission [9]. Moreover, mitochondria may act
as dynamic receivers, integrators, and transmitters of peroxisome-de-
rived mediators of oxidative stress, suggesting a potential broader role
for the peroxisome in regulating oxidative stress and adipogenesis
[97,98]. The intimate redox interplay between mitochondria and per-
oxisomes in regulation of signaling and metabolism makes it difficult to
estimate the relative contribution of peroxisomal ROS as compared to
mitochondrial ROS to these processes.
Peroxisomes oxidize a variety of FAs and generate peroxisomal
H2O2 by ACOX-mediated desaturation, while mitochondria are im-
portant for further metabolism of the end-products of peroxisomal β
oxidation which include chain-shortened acyl-CoAs, acetyl-CoA, pro-
pionyl-CoA as well as NADH. The transport of acyl-CoAs is achieved by
interconversion with their acyl carnitine counterparts catalyzed by
multiple carnitine acyltransferases and translocase. A recent study
identifies the peroxisome-mitochondrial contact by a proximity detec-
tion method based on split fluorophores, and demonstrates its con-
tribution to complete β-oxidation of FAs [99]. Moreover, cargo trans-
port from the mitochondria to peroxisomes can be achieved by
vesicular carriers [100], providing additional mechanism for active
substrate exchange between these two organelles.
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13. Conclusions and future perspectives
Adipocyte peroxisomes not only contribute significantly to the
synthesis of TAG and ether lipids via the DHAP pathway, but also
generate important lipid molecules and redox signals that influence
adipogenesis and adipocyte metabolism. Peroxisomes form close con-
tacts with various subcellular organelles, including the ER, LD and
mitochondria to coordinate key adipocyte functions of lipid synthesis,
lipolysis and FA oxidation. Importantly, peroxisomes are major site of
ROS/RNS formation and detoxification and are therefore important in
maintaining cellular redox homeostasis and regulating various sig-
naling cascades which are important in adipogenesis and adipocyte
functions.
Although convincing evidences have been provided to support that
peroxisomal redox signaling plays critical roles in regulating adipocyte
functions, the underlying mechanisms are still poorly understood.
Additional studies are necessary to answer how ROS signaling may
influence bioactive signaling lipid generation in adipocyte peroxisomes.
It is also not clear how ROS signaling influences remodeling of WAT
and regulation of whole body insulin sensitivity. A better understanding
of the specific roles of peroxisomes in different metabolic pathways and
their contribution to the pathogenesis of metabolic diseases could
identify novel directions and targets for treating patients with perox-
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